Repligen Corporation (RGEN)

Repligen Corp (RGEN) Shares Fall 7.7% -- What GF Score of 85 Tells Investors

Repligen Completes Acquisition of BioLife Solutions

Repligen Corp (RGEN) Stock Up 4.3% but GF Value Says Overvalued -- GF Score: 85/100

BioLife Solutions Shareholders Approve Repligen Merger Agreement

Repligen (NASDAQ:RGEN) Hits New 52-Week High – Still a Buy?

Tidal Investments LLC Raises Holdings in Repligen Corporation $RGEN

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

Repligen Corporation (RGEN) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Why Is Repligen (RGEN) Up 27.7% Since Last Earnings Report?

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen

American Capital Management Inc. Makes New $49.26 Million Investment in Repligen Corporation $RGEN

5 Biotech Stocks Worth Adding to Your Portfolio Now

Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference

25,992 Shares in Repligen Corporation $RGEN Acquired by Bank of Nova Scotia

Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.

B. Metzler seel. Sohn & Co. AG Takes $3.60 Million Position in Repligen Corporation $RGEN

Repligen Corporation $RGEN Shares Acquired by Avidity Partners Management LP

Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to Trade

Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up

Repligen Corporation (RGEN) Q2 2026 Earnings Call Transcript